Consultation on cannabis regulatory issues
From Health Canada
Current status: Closed
This consultation ran from December 12, 2020 to January 11, 2021.
The Notice of Intent in the Canada Gazette, Part I provided interested stakeholders with the opportunity to comment on Health Canada’s intent to amend the Cannabis Regulations and associated regulatory frameworks to allow for non-therapeutic cannabis research involving human participants and cannabis testing. This notice also provided interested stakeholders with the opportunity to provide feedback and comment on additional regulatory issues.
Who was the focus of this consultation
Health Canada engaged with Canadians, including:
- provinces, territories and municipalities
- Indigenous peoples
- the public health community
- law enforcement
Key issues discussed
The Notice of Intent touched on the following issues under the Cannabis Regulations:
- non-therapeutic cannabis research involving human participants
- cannabis testing
- public possession limits (namely, amounts of various classes of cannabis that are equivalent to 1 gram of dried cannabis, as set out in Schedule 3 to the Cannabis Act)
- product labelling requirements
- micro-class and nursery licensing regime
- measures to support cannabis licence holders with difficulties they might have because of COVID-19
The input gathered through this process will be used to inform regulatory development.
Strategic Policy, Cannabis
Controlled Substances and Cannabis Branch
Report a problem or mistake on this page
- Date modified: